AGP Picks
View all

Science & Technology Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science & Technology Watch.

Press releases published on September 28, 2026

KBR and Trinzic to Host Separate Investor Days in New York City
Zymeworks Announces Updated 2026 Financial Guidance and Final Transaction Details Following Theravance Biopharma Acquisition
MediciNova Announces Topline Results from  MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)
Hudbay Enhances Gold Production Profile at Snow Lake, Extends Reserve Mine Life to 18 Years and Identifies Further Growth Potential from Resource Conversion and the Britannia Gold Project
Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNA
OMS Energy Technologies (NASDAQ: OMSE) Secures US$9.4 Million in New Orders, Including US$7.1 Million Competitive Tender Win from Saudi Aramco
Lift Therapeutics Appoints Eva Ehrnrooth as Executive Head of Clinical Development and Adds Chau Khuong to Board of Directors
VEON and Banglalink Convene Global Investors in New York to Advance “Invest in Bangladesh NOW!”
NVIDIA Launches Open Agent Safety Platform to Secure Agents From Testing to Deployment
KAYTUS Introduces AI Managed Service for Data Centers
Atos appoints Paul Potgieter as Head of Middle East & Türkiye
إطلاق نهج طبي دولي جديد رسمياً في شنتشن بالصينيهدف إلى عكس مسار السكري
A New International Medical Approach Aimed at Reversing Diabetes has Officially Launched in Shenzhen, China
LEADING EDGE MATERIALS CLOSES C$6,000,000 PRIVATE PLACEMENT
Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Granted Orphan Drug Designation in Japan, Further Expanding Global Regulatory Recognition
Vocalbeats.AI Supports FutureChina Global Forum 2026 and Advances Practical AI Innovation
Alex Bodi and Prof. Dr Dieter Lazik sign a contract for ALPHA WHEY and BODI Energy Drink
Inventiva Reports Unaudited 2026 First-Half Financial Results and Provides Corporate Update
Inventiva publie ses résultats financiers non audités du premier semestre 2026 et fait le point sur ses activités
OSE Immunotherapeutics Reports its Cash Position as of June 30, 2026, and Provides Business Update

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Science & Technology Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.